{
    "clinical_study": {
        "@rank": "109298", 
        "arm_group": [
            {
                "arm_group_label": "Gynoclin V", 
                "arm_group_type": "Experimental", 
                "description": "One ovule containing 80 milligram (mg) terconazole, 100 mg clindamycin and 0.5 mg fluocinolone acetonide will be administered vaginally, every 24 hours at night,  for 3 days."
            }, 
            {
                "arm_group_label": "Vagitrol V", 
                "arm_group_type": "Experimental", 
                "description": "One ovule containing 500 mg metronidazole, 0.5 mg fluocinolone acetonide and 100,000.00 microgram/milliliter nystatin will be administered vaginally, every 24 hours at night, for 10 days."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this comparative study is to evaluate the efficacy of an ovule with triple\n      active agents (terconazole, clindamycin and fluocinolone) versus another ovule with triple\n      active agents (nystatin, metronidazole and fluocinolone) in the treatment of symptoms caused\n      by the presence of vaginitis (inflammation of the vagina) or bacterial vaginosis\n      (polymicrobial, nonspecific vaginitis associated with positive cultures of Gardnerella\n      vaginalis and other anaerobic organisms and a decrease in lactobacilli)."
        }, 
        "brief_title": "A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "One ovule containing 80 mg terconazole, 100 mg clindamycin and 0.5 mg fluocinolone acetonide was administered vaginally, every 24 hours at night, for 3 days.", 
                            "title": "Gynoclin V (Terconazole+Clindamycin+Fluocinolone Acetonide)"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "One ovule containing 500 mg metronidazole, 0.5 mg fluocinolone acetonide and 100,000.00 mcg/ml nystatin was administered vaginally, every 24 hours at night, for 10 days.", 
                            "title": "Vagitrol V (Metronidazole+Fluocinolone Acetonide+Nystatin)"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "81"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "79"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "160"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@spread": "7.17", 
                                                "@value": "30.69"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@spread": "7.50", 
                                                "@value": "30.56"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@spread": "7.33", 
                                                "@value": "30.63"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "description": "Participants who received at least 1 dose of study medication and who were evaluated for efficacy parameters were included in ITT population. A total of 81 participants in Gynoclin V and 78 participants in Vagitrol V were analyzed for this Baseline characteristic.", 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "Years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "81"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "79"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "160"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "0"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "Participants"
                        }
                    ]
                }, 
                "population": "Participants who received at least 1 dose of study medication and who were evaluated for efficacy parameters were included in Intent-to-treat (ITT) population."
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "Participants were evaluated for presence or absence of symptoms (itching, burning and sudden vulvar pain) in response to treatment.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "One ovule containing 80 mg terconazole, 100 mg clindamycin and 0.5 mg fluocinolone acetonide was administered vaginally, every 24 hours at night, for 3 days.", 
                                    "title": "Gynoclin V (Terconazole+Clindamycin+Fluocinolone Acetonide)"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "One ovule containing 500 mg metronidazole, 0.5 mg fluocinolone acetonide and 100,000.00 mcg/ml nystatin was administered vaginally, every 24 hours at night, for 10 days.", 
                                    "title": "Vagitrol V (Metronidazole+Fluocinolone Acetonide+Nystatin)"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "79"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "77"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "67.1"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "79.2"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Itching: Absent"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "32.9"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "20.8"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Itching: Present"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "78.5"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "88.3"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Burning: Absent"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "21.5"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "11.7"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Burning: Present"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "95.0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "90.9"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Sudden vulvar pain: Absent"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "5.0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "9.1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Sudden vulvar pain: Present"
                                            }
                                        ]
                                    }, 
                                    "description": "Participants were evaluated for presence or absence of symptoms (itching, burning and sudden vulvar pain) in response to treatment.", 
                                    "param": "Number", 
                                    "title": "Percentage of Participants With Presence or Absence of Symptoms 3 Days After Treatment", 
                                    "units": "Percentage of Participants"
                                }
                            ]
                        }, 
                        "population": "Participants who received at least 1 dose of study medication and who were evaluated for efficacy parameters were included in Intent-to-treat (ITT) population. Here 'N' specifies participants who were evaluated for this outcome measure.", 
                        "safety_issue": "No", 
                        "time_frame": "3 days after treatment (Day 7 for Gynoclin V or Day 13 for Vagitrol V)", 
                        "title": "Percentage of Participants With Presence or Absence of Symptoms 3 Days After Treatment", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Participants were evaluated for presence or absence of symptoms (itching, burning and sudden vulvar pain) in response to treatment.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "One ovule containing 80 mg terconazole, 100 mg clindamycin and 0.5 mg fluocinolone acetonide was administered vaginally, every 24 hours at night, for 3 days.", 
                                    "title": "Gynoclin V (Terconazole+Clindamycin+Fluocinolone Acetonide)"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "One ovule containing 500 mg metronidazole, 0.5 mg fluocinolone acetonide and 100,000.00 mcg/ml nystatin was administered vaginally, every 24 hours at night, for 10 days.", 
                                    "title": "Vagitrol V (Metronidazole+Fluocinolone Acetonide+Nystatin)"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "77"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "75"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "88.3"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "85.3"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Itching: Absent"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "11.7"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "14.7"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Itching: Present"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "93.5"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "92"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Burning: Absent"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "6.5"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "8"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Burning: Present"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "97.4"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "89.3"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Sudden vulvar pain: Absent"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "2.6"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "10.7"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Sudden vulvar pain: Present"
                                            }
                                        ]
                                    }, 
                                    "description": "Participants were evaluated for presence or absence of symptoms (itching, burning and sudden vulvar pain) in response to treatment.", 
                                    "param": "Number", 
                                    "title": "Percentage of Participants With Presence or Absence of Symptoms 8 Days After Treatment", 
                                    "units": "Percentage of Participants"
                                }
                            ]
                        }, 
                        "population": "Participants who received at least 1 dose of study medication and who were evaluated for efficacy parameters were included in ITT population. Here 'N' specifies participants who were evaluated for this outcome measure.", 
                        "safety_issue": "No", 
                        "time_frame": "8 days after treatment (Day 12 for Gynoclin V or Day 18 for Vagitrol V)", 
                        "title": "Percentage of Participants With Presence or Absence of Symptoms 8 Days After Treatment", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Percentage of participants with the presence of microorganisms (Candida albicans, Candida species, Gardnerella vaginalis, Vaginal flora, Lactobacillus species) in the wet mount, KOH, gram stain and vaginal discharge culture (candida and symptomatology) 3 days after treatment.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "One ovule containing 80 mg terconazole, 100 mg clindamycin and 0.5 mg fluocinolone acetonide was administered vaginally, every 24 hours at night, for 3 days.", 
                                    "title": "Gynoclin V (Terconazole+Clindamycin+Fluocinolone Acetonide)"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "One ovule containing 500 mg metronidazole, 0.5 mg fluocinolone acetonide and 100,000.00 mcg/ml nystatin was administered vaginally, every 24 hours at night, for 10 days.", 
                                    "title": "Vagitrol V (Metronidazole+Fluocinolone Acetonide+Nystatin)"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "78"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "76"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "2.5"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Candida albicans"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "9.8"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1.3"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Candida species, Gardnerella vaginalis"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "55.6"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "58.2"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Vaginal Flora"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "28.4"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "36.7"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Lactobacillus species"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "3.7"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "3.8"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "No culture performed"
                                            }
                                        ]
                                    }, 
                                    "description": "Percentage of participants with the presence of microorganisms (Candida albicans, Candida species, Gardnerella vaginalis, Vaginal flora, Lactobacillus species) in the wet mount, KOH, gram stain and vaginal discharge culture (candida and symptomatology) 3 days after treatment.", 
                                    "param": "Number", 
                                    "title": "Percentage of Participants With the Presence of Microorganisms (Single-celled, Tiny Organisms That Include Fungi, Bacteria, Viruses) 3 Days After Treatment", 
                                    "units": "Percentage of Participants"
                                }
                            ]
                        }, 
                        "population": "Participants who received at least 1 dose of study medication and who were evaluated for efficacy parameters were included in ITT population. Here 'N' signifies participants who were evaluated for this outcome measure including the participants for whom no culture was performed.", 
                        "safety_issue": "No", 
                        "time_frame": "3 days after treatment (Day 7 for Gynoclin V or Day 13 for Vagitrol V)", 
                        "title": "Percentage of Participants With the Presence of Microorganisms (Single-celled, Tiny Organisms That Include Fungi, Bacteria, Viruses) 3 Days After Treatment", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Response to treatment was evaluated by participant using a 5-point numerical scale: 1=No response (no improvement or condition even worsened); 2=Poor (No symptoms disappeared and symptoms are moderate to severe) 3=Moderate (improvement and symptoms are of moderate intensity); 4=Good (much improvement, but there are still some occasional mild symptoms); 5=Excellent (all symptoms disappeared).", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "One ovule containing 80 mg terconazole, 100 mg clindamycin and 0.5 mg fluocinolone acetonide was administered vaginally, every 24 hours at night, for 3 days.", 
                                    "title": "Gynoclin V (Terconazole+Clindamycin+Fluocinolone Acetonide)"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "One ovule containing 500 mg metronidazole, 0.5 mg fluocinolone acetonide and 100,000.00 mcg/ml nystatin was administered vaginally, every 24 hours at night, for 10 days.", 
                                    "title": "Vagitrol V (Metronidazole+Fluocinolone Acetonide+Nystatin)"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "77"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "75"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "1.30"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1.30"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Poor"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "4.00"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Moderate"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "36.40"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "29.40"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Good"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "62.30"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "65.30"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Excellent"
                                            }
                                        ]
                                    }, 
                                    "description": "Response to treatment was evaluated by participant using a 5-point numerical scale: 1=No response (no improvement or condition even worsened); 2=Poor (No symptoms disappeared and symptoms are moderate to severe) 3=Moderate (improvement and symptoms are of moderate intensity); 4=Good (much improvement, but there are still some occasional mild symptoms); 5=Excellent (all symptoms disappeared).", 
                                    "param": "Number", 
                                    "title": "Percentage of Participants With Response to Treatment Assessed by Participant", 
                                    "units": "Percentage of Participants"
                                }
                            ]
                        }, 
                        "population": "Participants who received at least 1 dose of study medication and who were evaluated for efficacy parameters were included in ITT population. Here 'N' specifies participants who were evaluated for this outcome measure.", 
                        "safety_issue": "No", 
                        "time_frame": "8 days after treatment (Day 12 for Gynoclin V or Day 18 for Vagitrol V)", 
                        "title": "Percentage of Participants With Response to Treatment Assessed by Participant", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Response to treatment was evaluated by Physician using a 5-point numerical scale: 1=No response (no improvement or condition even worsened); 2=Poor (No symptoms disappeared and symptoms are moderate to severe) 3=Moderate (improvement and symptoms are of moderate intensity); 4=Good (much improvement, but there are still some occasional mild symptoms); 5=Excellent (all symptoms disappeared).", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "One ovule containing 80 mg terconazole, 100 mg clindamycin and 0.5 mg fluocinolone acetonide was administered vaginally, every 24 hours at night, for 3 days.", 
                                    "title": "Gynoclin V (Terconazole+Clindamycin+Fluocinolone Acetonide)"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "One ovule containing 500 mg metronidazole, 0.5 mg fluocinolone acetonide and 100,000.00 mcg/ml nystatin was administered vaginally, every 24 hours at night, for 10 days.", 
                                    "title": "Vagitrol V (Metronidazole+Fluocinolone Acetonide+Nystatin)"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "77"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "75"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "1.30"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1.30"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Poor"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "5.30"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Moderate"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "28.60"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "26.70"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Good"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "70.10"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "66.70"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Excellent"
                                            }
                                        ]
                                    }, 
                                    "description": "Response to treatment was evaluated by Physician using a 5-point numerical scale: 1=No response (no improvement or condition even worsened); 2=Poor (No symptoms disappeared and symptoms are moderate to severe) 3=Moderate (improvement and symptoms are of moderate intensity); 4=Good (much improvement, but there are still some occasional mild symptoms); 5=Excellent (all symptoms disappeared).", 
                                    "param": "Number", 
                                    "title": "Percentage of Participants With Response to Treatment Assessed by Physician", 
                                    "units": "Percentage of Participants"
                                }
                            ]
                        }, 
                        "population": "Participants who received at least 1 dose of study medication and who were evaluated for efficacy parameters were included in ITT population. Here 'N' specifies participants who were evaluated for this outcome measure.", 
                        "safety_issue": "No", 
                        "time_frame": "8 days after treatment (Day 12 for Gynoclin V or Day 18 for Vagitrol V)", 
                        "title": "Percentage of Participants With Response to Treatment Assessed by Physician", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "One ovule containing 80 milligram (mg) terconazole, 100 mg clindamycin and 0.5 mg fluocinolone acetonide was administered vaginally, every 24 hours at night, for 3 days.", 
                            "title": "Gynoclin V (Terconazole+Clindamycin+Fluocinolone Acetonide)"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "One ovule containing 500 mg metronidazole, 0.5 mg fluocinolone acetonide and 100,000.00 microgram/milliliter (mcg/ml) nystatin was administered vaginally, every 24 hours at night, for 10 days.", 
                            "title": "Vagitrol V (Metronidazole+Fluocinolone Acetonide+Nystatin)"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "81", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "79", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "81", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "79", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "0", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }
            }, 
            "point_of_contact": {
                "name_or_title": "Clinical Research Director", 
                "organization": "Global Clinical Operations Mexico", 
                "phone": "+52 55 5484 3184"
            }, 
            "reported_events": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "One ovule containing 80 mg terconazole, 100 mg clindamycin and 0.5 mg fluocinolone acetonide was administered vaginally, every 24 hours at night, for 3 days.", 
                            "title": "Gynoclin V (Terconazole+Clindamycin+Fluocinolone Acetonide)"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "One ovule containing 500 mg metronidazole, 0.5 mg fluocinolone acetonide and 100,000.00 mcg/ml nystatin was administered vaginally, every 24 hours at night, for 10 days.", 
                            "title": "Vagitrol V (Metronidazole+Fluocinolone Acetonide+Nystatin)"
                        }
                    ]
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "81"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "79"
                                            }
                                        ], 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "81"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "79"
                                            }
                                        ], 
                                        "sub_title": "Fungal Infections"
                                    }
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "81"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "79"
                                            }
                                        ], 
                                        "sub_title": "Headache"
                                    }
                                }, 
                                "title": "Nervous system disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Non-systematic Assessment", 
                    "default_vocab": "MedDRA", 
                    "frequency_threshold": "0"
                }, 
                "time_frame": "Baseline up to Day 13 for Gynoclin V and Day 18 for Vagitrol V"
            }
        }, 
        "completion_date": {
            "#text": "December 2008", 
            "@type": "Actual"
        }, 
        "condition": [
            "Vaginitis", 
            "Infectious Vaginosis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Communicable Diseases", 
                "Infection", 
                "Vaginitis"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a prospective (study following participants forward in time), open-label (all people\n      know the identity of the intervention), randomized (the study drug is assigned by chance),\n      comparative, parallel (a clinical trial comparing the response in 2 or more groups of\n      participants receiving different treatments) double-arm, multi-center (when more than 1\n      hospital or medical school team work on a medical research study) study. The study consists\n      of 3 phases: Screening phase on Visit 1 (Day -3/1); Inclusion or treatment phase on Visit 2\n      (Day 1); and Treatment or monitoring phase (3 days after treatment) on Visit 3 (Day 7 for\n      Gynoclin V and Day 13 for Vagitrol V) and Visit 4 (Day 12 for Gynoclin V and Day 18 for\n      Vagitrol V). Participants will be randomly assigned to 1 of the 2 treatment groups: Gynoclin\n      V and Vagitrol V. Participants in Gynoclin V group will be administered 1 ovule (containing\n      80 milligram [mg] terconazole, 100 mg clindamycin and 0.5 mg fluocinolone acetonide)\n      vaginally every 24 hours at night, for 3 days. Participants in the Vagitrol V group will be\n      administered 1 ovule (containing 500 mg metronidazole, 0.5 mg fluocinolone acetonide and\n      100,000.00 microgram/milliliter nystatin) vaginally every 24 hours at night,  for 10 days.\n      Primarily, participants will be evaluated for signs and symptoms, characteristics of vaginal\n      discharge, changes in vulvar region, changes in cervix and presence of bacteria, fungi\n      and/or parasites. Participants' safety will be monitored throughout the study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Participants presenting clinical symptoms compatible with vaginitis/bacterial\n             vaginosis, with any of the following symptoms being the reason for the consultation:\n             pruritus (itchiness), vulvar burning, as well as presenting leukorrhea (a clear or\n             white discharge from the vagina, consisting mainly of mucus) as an accompanying\n             symptom\n\n          -  Participant who agrees to return at the 7th and 13th day after starting the treatment\n\n          -  Participant who agrees to abstain from sexual relations for the 13 days of the study\n\n          -  Participant who have signed informed consent to participate in the study\n\n        Exclusion Criteria:\n\n          -  Participant with a known allergy to vaginal treatments\n\n          -  Participants who have received treatment for the current condition in the 10 days\n             before the date of inclusion, or is currently receiving antibiotics (drug used to\n             stop or slow down the growth of germs), antifungals, anti-parasitics or systemic\n             steroids\n\n          -  Participant with suspected pregnancy or currently breastfeeding\n\n          -  Participant who has received unknown drugs or experimental drugs within the 3 months\n             before inclusion\n\n          -  Participant known to be a carrier of a severe (very serious, life threatening)\n             disease that alters the metabolism or excretion of the drugs used (liver or kidney\n             disease)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 29, 2013", 
        "firstreceived_results_date": "July 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01867164", 
            "org_study_id": "CR100569", 
            "secondary_id": "TEROV8BAC4001"
        }, 
        "intervention": [
            {
                "arm_group_label": "Gynoclin V", 
                "description": "One ovule containing 80 milligram (mg) terconazole, 100 mg clindamycin and 0.5 mg fluocinolone acetonide will be administered vaginally, every 24 hours at night, for 3 days.", 
                "intervention_name": "Gynoclin V", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Vagitrol V", 
                "description": "One ovule containing 500 mg metronidazole, 0.5 mg fluocinolone acetonide and 100,000.00 microgram/milliliter nystatin will be administered vaginally, every 24 hours at night, for 10 days.", 
                "intervention_name": "Vagitrol V", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Clindamycin", 
                "Clindamycin-2-phosphate", 
                "Nystatin", 
                "Terconazole", 
                "Metronidazole", 
                "Fluocinolone Acetonide"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Vaginitis", 
            "Infectious vaginosis", 
            "Terconazole", 
            "Clindamycin", 
            "Fluocinolone", 
            "Metronidazole", 
            "Nystatin"
        ], 
        "lastchanged_date": "November 1, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "DF", 
                        "country": "Mexico"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mexico D.F.", 
                        "country": "Mexico"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": "Mexico"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Open-Label, Comparative, Parallel Double-Arm, Multicentric Clinical Study to Evaluate the Efficacy of an Ovule With Triple Active Agents (Terconazole, Clindamycin, Fluocinolone) Administered Once Per Day for Three Days Versus an Ovule With Triple Active Agents (Metronidazole, Nystatin, Fluocinolone) Administered Once Per Day for Ten Days to Treat Secondary Vulvar/Vaginal Symptoms of Vaginitis/Infectious Vaginosis (Bacterial and/or Mycotic and/or Parasitic)", 
        "overall_official": {
            "affiliation": "Janssen-Cilag, S.A.", 
            "last_name": "Janssen-Cilag S.A. Clinical Trial", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Mexico: Federal Commission for Protection Against Health Risks", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2008", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Participants were evaluated for presence or absence of symptoms (itching, burning and sudden vulvar pain) in response to treatment.", 
                "measure": "Percentage of Participants With Presence or Absence of Symptoms 3 Days After Treatment", 
                "safety_issue": "No", 
                "time_frame": "3 days after treatment (Day 7 for Gynoclin V or Day 13 for Vagitrol V)"
            }, 
            {
                "description": "Participants were evaluated for presence or absence of symptoms (itching, burning and sudden vulvar pain) in response to treatment.", 
                "measure": "Percentage of Participants With Presence or Absence of Symptoms 8 Days After Treatment", 
                "safety_issue": "No", 
                "time_frame": "8 days after treatment (Day 12 for Gynoclin V or Day 18 for Vagitrol V)"
            }, 
            {
                "description": "Percentage of participants with the presence of microorganisms (Candida albicans, Candida species, Gardnerella vaginalis, Vaginal flora, Lactobacillus species) in the wet mount, KOH, gram stain and vaginal discharge culture (candida and symptomatology) 3 days after treatment.", 
                "measure": "Percentage of Participants With the Presence of Microorganisms (Single-celled, Tiny Organisms That Include Fungi, Bacteria, Viruses) 3 Days After Treatment", 
                "safety_issue": "No", 
                "time_frame": "3 days after treatment (Day 7 for Gynoclin V or Day 13 for Vagitrol V)"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01867164"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Response to treatment was evaluated by participant using a 5-point numerical scale: 1=No response (no improvement or condition even worsened); 2=Poor (No symptoms disappeared and symptoms are moderate to severe) 3=Moderate (improvement and symptoms are of moderate intensity); 4=Good (much improvement, but there are still some occasional mild symptoms); 5=Excellent (all symptoms disappeared).", 
                "measure": "Percentage of Participants With Response to Treatment Assessed by Participant", 
                "safety_issue": "No", 
                "time_frame": "8 days after treatment (Day 12 for Gynoclin V or Day 18 for Vagitrol V)"
            }, 
            {
                "description": "Response to treatment was evaluated by Physician using a 5-point numerical scale: 1=No response (no improvement or condition even worsened); 2=Poor (No symptoms disappeared and symptoms are moderate to severe) 3=Moderate (improvement and symptoms are of moderate intensity); 4=Good (much improvement, but there are still some occasional mild symptoms); 5=Excellent (all symptoms disappeared).", 
                "measure": "Percentage of Participants With Response to Treatment Assessed by Physician", 
                "safety_issue": "No", 
                "time_frame": "8 days after treatment (Day 12 for Gynoclin V or Day 18 for Vagitrol V)"
            }
        ], 
        "source": "Janssen-Cilag, S.A.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Janssen-Cilag, S.A.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2007", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}